 |
|
|
|---|---|---|
|
|
Transplantation
______________________________________________________________________________________ Publications Questionable model choice in valve calcification research addressing alpha-Gal. Mangold A, Ankersmit HJ. J Heart Lung Transplant. 2010 Aug;29(8):911-2; discussion 912-3. Epub 2010 Jun 8. Considerations on infectious complications using a drowned lung for transplantation. Hoetzenecker K, Ankersmit HJ, Lang G, Scheed A, Marta G, Jaksch P, Klepetko W. Transpl Int. 2010 May 5. Alpha-Gal Specific IgG Immune Response after Implantation of Bioprostheses Blockade of RAGE suppresses alloimmune reactions in vitro and delays allograft rejection in murine heart transplantation. Moser B, Szabolcs MJ, Ankersmit HJ, Lu Y, Qu W, Weinberg A, Herold KC, Schmidt AM; American journal of transplantation 2007 Feb;7(2):293-302. Abstract
Endothelin activation and postoperative renal failure after human liver transplantation. Hetz H, Bauer M, Lahner D, Faybik P, Winning J, Ankersmit HJ, Bacher A, Krenn CG; Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2005 Oct;11(10):1201-6. Abstract Is the transpulmonary pressure gradient a predictor for mortality after orthotopic cardiac transplantation? Gorlitzer M, Ankersmit J, Fiegl N, Meinhart J, Lanzenberger M, Unal K, Dunkler D, Kilo J, Wolner E, Grimm M, Grabenwoeger M; Transplant international : official journal of the European Society for Organ Transplantation 2005 Apr;18(4):390-5. Abstract Alpha-Gal on bioprostheses: xenograft immune response in cardiac surgery. Konakci KZ, Bohle B, Blumer R, Hoetzenecker W, Roth G, Moser B, Boltz-Nitulescu G, Gorlitzer M, Klepetko W, Wolner E, Ankersmit HJ; European journal of clinical investigation 2005 Jan;35(1):17-23. Abstract Size-reduced lung transplantation: an advanced operative strategy to alleviate donor organ shortage. Aigner C, Winkler G, Jaksch P, Ankersmit J, Marta G, Taghavi S, Wisser W, Klepetko W; Transplantation proceedings 2004 Nov;36(9):2801-5. Abstract Extracorporeal membrane oxygenation is superior to right ventricular assist device for acute right ventricular failure after heart transplantation. Taghavi S, Zuckermann A, Ankersmit J, Wieselthaler G, Rajek A, Laufer G, Wolner E, Grimm M; The Annals of thoracic surgery 2004 Nov;78(5):1644-9. Abstract Thrombophilia associated with anti-CD154 monoclonal antibody treatment and its prophylaxis in nonhuman primates. Roth GA, Zuckermann A, Klepetko W, Wolner E, Ankersmit HJ, Moser B, Volf I; Transplantation 2004 Oct 27;78(8):1238-9. Abstract Comparison of combined prophylaxis of cytomegalovirus hyperimmune globulin plus ganciclovir versus cytomegalovirus hyperimmune globulin alone in high-risk heart transplant recipients. Bonaros NE, Kocher A, Dunkler D, Grimm M, Zuckermann A, Ankersmit J, Ehrlich M, Wolner E, Laufer G; Transplantation 2004 Mar 27;77(6):890-7. Abstract Long-term survival (>10 years) of patients >60 years with induction therapy after cardiac transplantation. Zuckermann A, Dunkler D, Deviatko E, Bodhjalian A, Czerny M, Ankersmit J, Wolner E, Grimm M; European journal of cardio-thoracic surgery 2003 Aug;24(2):283-91. Abstract Rapamycin as rescue therapy in a patient supported by biventricular assist device to heart transplantation with consecutive ongoing rejection. Ankersmit HJ, Roth G, Zuckermann A, Moser B, Obermaier R, Taghavi S, Brunner M, Wieselthaler G, Lanzenberger M, Ullrich R, Laufer G, Grimm M, Wolner E; American journal of transplantation 2003 Feb;3(2):231-4. Abstract Mycophenolate mofetil reduces anti-HLA antibody production and cellular rejection in heart transplant recipients. Lietz K, John R, Schuster M, Ankersmit J, Burke E, Suciu-Foca N, Edwards N, Mancini D, Itescu S; Transplantation proceedings 2002 Aug;34(5):1828-9. Abstract Activation-induced T cell death, and aberrant T cell activation via TNFR1 and CD95-CD95 ligand pathway in stable cardiac transplant recipients. Ankersmit HJ, Moser B, Zuckermann A, Roth G, Taghavi S, Brunner M, Wolner E, Boltz-Nitulescu G; Clinical and experimental immunology 2002 Apr;128(1):175-80. Abstract Transitory immunologic response after implantation of the DeBakey VAD continuous-axial-flow pump. Ankersmit HJ, Wieselthaler G, Moser B, Gerlitz S, Roth G, Boltz-Nitulescu G, Wolner E; The Journal of thoracic and cardiovascular surgery 2002 Mar;123(3):557-61. Abstract Death-inducing receptors and apoptotic changes in lymphocytes of patients with heart transplant vasculopathy. Ankersmit HJ, Moser B, Roedler S, Teufel I, Zuckermann A, Roth G, Lietz K, Back C, Gerlitz S, Wolner E, Boltz-Nitulescu G; Clinical and experimental immunology 2002 Jan;127(1):183-9. Abstract Backtable ventricular and atrial septal defect repair of an Eisenmenger allograft with concomitant domino heart transplantation. Gorlitzer M, Ankersmit HJ, Wollenek G, Wisser W, Wieselthaler G, Haisjackl M, Horvat R, Gabriel H, Wolner E, Grimm M; The Journal of thoracic and cardiovascular surgery 2002 Feb;123(2):374-6. Abstract Extracorporeal membrane oxygenation for graft failure after heart transplantation: recent Vienna experience. Taghavi S, Ankersmit HJ, Wieselthaler G, Gorlitzer M, Rajek A, Wolner E, Grimm M; The Journal of thoracic and cardiovascular surgery 2001 Oct;122(4):819-20. Abstract Aberrant T-cell activation via CD95 and apoptosis in peripheral T lymphocytes in stable heart transplant recipients. Ankersmit HJ, Moser B, Hoffman M, Kocher AA, Schlechta B, Boltz-Nitulescu G, Wolner E; Transplantation proceedings 2001 Aug;33(5):2860-1. Abstract Outcome of pediatric heart transplantation: an analysis of 27 cases. Schlechta B, Kocher AA, Ehrlich M, Ankersmit J, Ploner M, Walch K, Nourani F, Czerny M, Wolner E, Wollenek G, Grimm M; Transplantation proceedings 2001 Aug;33(5):2834-5. Abstract Heart retransplantation: institutional results of a series of 31 cases. Schlechta B, Kocher AA, Ehrlich M, Ankersmit J, Ploner M, Walch K, Nourani F, Czerny M, Wolner E, Grimm M; Transplantation proceedings Aug;33(5):2759-61. Abstract Etiology of pulmonary nodules after heart transplantation. Kocher AA, Funovics M, Khazen C, Ploner M, Ehrlich M, Schlechta B, Nourani F, Ankersmit J, Wolner E, Laufer G; Transplantation proceedings 2001 Aug;33(5):2757-8. Abstract Effect of ABO blood type matching in cardiac transplant recipients. Kocher AA, Schlechta B, Ehrlich M, Ploner M, Khazen C, Schuster MP, Ankersmit J, Grimm M, Wolner E, Laufer G, Lassnigg A, Bonaros N; Transplantation proceedings 2001 Aug;33(5):2752-4. Abstract Pretransplant cachexia and morbid obesity are predictors of increased mortality after heart transplantation. Lietz K, John R, Burke EA, Ankersmit JH, McCue JD, Naka Y, Oz MC, Mancini DM, Edwards NM; Transplantation 2001 Jul 27;72(2):277-83. Abstract Automated implantable cardiac defibrillator and biventricular Thoratec assist device as bridge to transplantation in a patient with sarcoidosis. Ankersmit HJ, Wieselthaler GA, Moser B, Taghavi S, Grimm M, Roth G, Gorlitzer M, Tschernich H, Horvat R, Wolner E; The Journal of thoracic and cardiovascular surgery 2001 Jun;121(6):1198-9. Abstract Effect of obesity on outcome after cardiac transplantation. Kocher AA, Ankersmit J, Khazen C, Ofner P, Zuckermann A, Grimm M, Schlechta B, Ehrlich M, Wolner E, Laufer G; Transplantation proceedings 1999 Dec;31(8):3187-9. Abstract Modified technique of delivering solutions to rat coronary arteries in the transplant setting. Nourani F, Laufer G, Hollensteiner H, Bergmeister H, Buschle M, Khazen C, Ankersmit J, Traxler H, Wolner E, Losert U, Kocher AA; Transplantation proceedings 1999 Dec;31(8):3255-6. Abstract Repair of an aortic aneurysm at the time of heart transplantation: report of two cases and review of the literature. Kocher A, Ehrlich M, Khazen C, Ankersmit J, Nourani F, Itescu S, Edwards NM, Wolner E, Laufer G; Transplantation proceedings 1999 Dec;31(8):3184-6. Abstract Midterm results after combined heart and kidney transplantation. Kocher AA, Khazen C, Ankersmit J, Ofner P, Schlechta B, Ehrlich M, Wolner E, Laufer G; Transplantation proceedings 1999 Dec;31(8):3181-3. Abstract Intravenous immunoglobulin reduces anti-HLA alloreactivity and shortens waiting time to cardiac transplantation in highly sensitized left ventricular assist device recipients. John R, Lietz K, Burke E, Ankersmit J, Mancini D, Suciu-Foca N, Edwards N, Rose E, Oz M, Itescu S; Circulation 1999 Nov 9;100(19 Suppl):II229-35. Abstract Quantitative changes in T-cell populations after left ventricular assist device implantation: relationship to T-cell apoptosis and soluble CD95. Ankersmit HJ, Edwards NM, Schuster M, John R, Kocher A, Rose EA, Oz M, Itescu S; Circulation 1999 Nov 9;100(19 Suppl):II211-5. Abstract Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device. Ankersmit HJ, Tugulea S, Spanier T, Weinberg AD, Artrip JH, Burke EM, Flannery M, Mancini D, Rose EA, Edwards NM, Oz MC, Itescu S; Lancet 1999 Aug 14;354(9178):550-5. Abstract Combined heart and kidney transplantation using a single donor: a single center's experience with nine cases. Kocher AA, Schlechta B, Kopp CW, Ehrlich M, Ankersmit J, Ofner P, Langer F, Berlakovich GA, Grimm M, Wolner E, Laufer G; Transplantation 1998 Dec 27;66(12):1760-3. Abstract Importance of CD49d-VCAM interactions in human monocyte adhesion to porcine endothelium. Kwiatkowski P, Artrip JH, Ankersmit J, Schuster M, John R, Wang SF, Ma N, Michler RE, Itescu S; Xenotransplantation 1998 Feb;5(1):67-74.Abstract Role of natural killer cells, macrophages, and accessory molecule interactions in the rejection of pig-to-primate xenografts beyond the hyperacute period. Itescu S, Kwiatkowski P, Artrip JH, Wang SF, Ankersmit J, Minanov OP, Michler RE; Human immunology 1998 May;59(5):275-86. Abstract
|
